Luis C. Pena
President & CEO at Evommune Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 1 year
- Director since
- 2025
1 year of board service in total across 1 board, counting each seat separately. Longest: Evommune Inc., 1 year.
Chief executive roles
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 100
85.7% a year in revenue
20% of the scoring weight is on file. Figures cover December 2024 – December 2025.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Evommune Inc. June 2, 202691.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | Evommune Inc. | Open-market sale | −7,438 | $22.71 | $168,917 |
| Jun 1, 2026 | Evommune Inc. | Open-market sale | −16,787 | $22.74 | $381,736 |
| Dec 9, 2025 | Evommune Inc. | Shares withheld for tax | −28,138 | $17.84 | $501,982 |
| Nov 7, 2025 | Evommune Inc. | Derivative conversion | +24,225 | — | — |
Questions about Luis C. Pena
What boards is Luis C. Pena on?
Luis C. Pena sits on the board of Evommune Inc.
What company is Luis C. Pena the CEO of?
Luis C. Pena has been President & CEO of Evommune Inc. since November 2025.
How long has Luis C. Pena served on boards?
Our records show at least 1 year of board service across 1 board, the earliest from 2025.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.